BlackRock LifePath ESG Index 2030 K (LENKX)
Nasdaq • Currently up 0.02 (+0.15%) in today's trading session
1 member of Congress has disclosed 1 trade in BlackRock LifePath ESG Index 2030 K (LENKX) via STOCK Act filings. The most recent disclosure was a purchase by Andrea Salinas on 1 April 2025. Aggregate disclosed activity totals roughly $32.5K in purchases (midpoint estimates from bracketed disclosure amounts).
BlackRock LifePath ESG Index 2030 K is currently trading at $13.47, positioned at 98% of its 52-week range ($12.17 – $13.49).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
BlackRock LifePath ESG Index 2030 K Price History and Technical Analysis
Congressional Trading Activity for LENKX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about LENKX
- Which members of Congress have traded LENKX?
- 1 member of Congress has disclosed 1 trade in BlackRock LifePath ESG Index 2030 K (LENKX) under the STOCK Act: Andrea Salinas.
- When was LENKX most recently disclosed by Congress?
- The most recent LENKX disclosure was a purchase by Andrea Salinas on 1 April 2025.
- What is the total disclosed congressional trading volume for LENKX?
- Members of Congress have disclosed approximately $32.5K in LENKX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in LENKX?
- This LENKX page updates as soon as new STOCK Act disclosures are filed for BlackRock LifePath ESG Index 2030 K. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track LENKX in Congress
See when politicians buy or sell this stock